Blueprint Medicines Newsroom

Blueprint Medicines (BPMC) Up 8.7% Since Last Earnings Report: Can It Continue?

Yahoo FinanceNov 30 00:31

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025

Seeking AlphaNov 26 04:10

Breakeven On The Horizon For Blueprint Medicines Corporation (NASDAQ:BPMC)

Simply Wall StNov 24 20:19

Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing

MT NewswiresNov 23 05:53

Express News | Blueprint Medicines Corp : Raymond James Raises Target Price to $130 From $125

BreakingsNov 18 20:43

JMP Securities Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $125

Futu NewsNov 18 13:32 · Ratings

TD Cowen Maintains Blueprint Medicines(BPMC.US) With Buy Rating

Futu NewsNov 15 21:35 · Ratings

H.C. Wainwright Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $135

Futu NewsNov 15 19:34 · Ratings

Needham Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $135

Futu NewsNov 15 18:31 · Ratings

Morgan Stanley Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $120

Futu NewsNov 15 18:31 · Ratings

Needham Reiterates Buy on Blueprint Medicines, Maintains $135 Price Target

BenzingaNov 15 18:07 · Ratings

Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst

BenzingaNov 15 04:18

J.P. Morgan Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $126

Futu NewsNov 14 18:31 · Ratings

Express News | Blueprint Medicines Corp : JP Morgan Initiates Coverage With Overweight Rating; Target Price $126

BreakingsNov 14 13:40

Barclays Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $105

Futu NewsNov 6 03:33 · Ratings

Mixed Efficacy and Safety Profiles Lead to Hold Rating for Blueprint Medicines and Cogent Biosciences

TipRanksNov 6 02:55 · Ratings

Unusual Options Activity: MSFT, SATS and Others Attract Market Bets, MSFT V/OI Ratio Reaches 90.2

EST Nov 4th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

Futu NewsNov 5 00:30

Analysts Have Made A Financial Statement On Blueprint Medicines Corporation's (NASDAQ:BPMC) Third-Quarter Report

Yahoo FinanceNov 2 22:11

A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $105 to $135

Futu NewsNov 1 21:00 · Ratings

Wells Fargo Maintains Overweight on Blueprint Medicines, Lowers Price Target to $151

BenzingaNov 1 03:46 · Ratings